Chest Computed Tomography (CT) Screening Study With Antibody Testing

This study has been withdrawn prior to enrollment.
(Due to lack of funding)
Sponsor:
Information provided by:
Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01203579
First received: September 15, 2010
Last updated: June 20, 2012
Last verified: June 2012
  Purpose

The purpose of this study is to assess the value of EarlyCDT-Lung test and CT scan both in lung cancer detection and potential health economic outcomes.


Condition
Lung Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Different Strategies Using Autoantibodies and/or CT in the Detection of Lung Cancer

Resource links provided by NLM:


Further study details as provided by Mayo Clinic:

Enrollment: 0
Study Start Date: September 2011
Study Completion Date: September 2011
Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)
Detailed Description:

EarlyCDT-Lung test and CT scan both for lung cancer detection and potential economic outcomes.

  Eligibility

Ages Eligible for Study:   50 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Current or Former Smokers with >20 pack year history and or family history of lung cancer. Ages 50-75 years old

Criteria
  • Persons 50-75
  • Asymptomatic for lung cancer
  • Current or former (stopped smoking less than 10 years ago) cigarette smokers
  • History of cigarette smoking of at least 20 pack years
  • History of cigarette smoking with a family history of lung cancer which gives an individual a personal risk similar to a smoking history of 20 pk/years (i.e. 1% at 5 years).
  • Mentally competent individuals to sign an informed consent.
  • Healthy enough to undergo pulmonary resection or stereotactic body radiotherapy.
  • A fully informed signed consent form must have been obtained.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01203579

Locations
United States, Minnesota
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Sponsors and Collaborators
Mayo Clinic
Investigators
Principal Investigator: David Midthun, MD Mayo Clinic
  More Information

No publications provided

Responsible Party: David Midthun, MD, Mayo Clinic
ClinicalTrials.gov Identifier: NCT01203579     History of Changes
Other Study ID Numbers: 10-003048
Study First Received: September 15, 2010
Last Updated: June 20, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Mayo Clinic:
CDT-Lung,CT scan,lung cancer detection

Additional relevant MeSH terms:
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on July 31, 2014